Related Experiment Video
Updated: Aug 16, 2026

09:12
MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells
Published on: December 21, 2011
LY-544344. Eli Lilly
1Merz Pharmaceuticals GmbH, Department of Behavioural Pharmacology, Eckenheimer Landstrasse 100, Frankfurt am Main, D-30618, Germany. Wojciech.Danysz@merz.de
Abstract:
Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the potential treatment of anxiety disorders.

